肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

人类癌症中的非编码驱动突变

Non-coding driver mutations in human cancer

原文发布日期:2021-07-06

DOI: 10.1038/s41568-021-00371-z

类型: Review Article

开放获取: 否

英文摘要:

摘要翻译: 

原文链接:

文章:

人类癌症中的非编码驱动突变

Non-coding driver mutations in human cancer

原文发布日期:2021-07-06

DOI: 10.1038/s41568-021-00371-z

类型: Review Article

开放获取: 否

 

英文摘要:

Tumour formation involves random mutagenic events and positive evolutionary selection acting on a subset of such events, referred to as driver mutations. A decade of careful surveying of tumour DNA using exome-based analyses has revealed a multitude of protein-coding somatic driver mutations, some of which are clinically actionable. Today, a transition towards whole-genome analysis is well under way, technically enabling the discovery of potential driver mutations occurring outside protein-coding sequences. Mutations are abundant in this vast non-coding space, which is more than 50 times larger than the coding exome, but reliable identification of selection signals in non-coding DNA remains a challenge. In this Review, we discuss recent findings in the field, where the emerging landscape is one in which non-coding driver mutations appear to be relatively infrequent. Nevertheless, we highlight several notable discoveries. We consider possible reasons for the relative absence of non-coding driver events, as well as the difficulties associated with detecting signals of positive selection in non-coding DNA.

 

摘要翻译: 

肿瘤形成涉及随机突变事件以及对此类事件中一部分(即驱动突变)起作用的积极进化选择。基于外显子组的肿瘤DNA细致筛查研究已开展十年,揭示了大量蛋白质编码体细胞驱动突变,其中部分具有临床可行性。当前,该领域正全面转向全基因组分析,这在技术上使得发现蛋白质编码序列之外潜在驱动突变成为可能。在这片超过编码外显子组50倍规模的广阔非编码区域内,突变极为丰富,但可靠识别非编码DNA中阳性选择信号仍面临挑战。本文综述讨论了该领域最新发现,现有研究图景显示非编码驱动突变似乎相对罕见。尽管如此,我们仍重点阐述了若干值得关注的发现,并探讨了非编码驱动事件相对缺失的可能原因,以及检测非编码DNA中阳性选择信号所面临的困难。

 

原文链接:

Non-coding driver mutations in human cancer

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……